pharmaceuticals
pharmaceuticals Articles
Eli Lilly is cutting about 8% of its global workforce in a "streamlining and focusing" effort as part of a cost structure initiative.
Published:
Last Updated:
Verastem saw perhaps the biggest gain in the market Wednesday after the company announced positive late-stage results.
Published:
Last Updated:
A study found that while evidence of misuse has declined in recent years, more than half of test results showed evidence of potential misuse, suggesting most patients took their prescribed drugs in...
Published:
Last Updated:
Sarepta Therapeutics saw its shares make a handy gain on Wednesday after the firm announced muscle biopsy results from its mid-stage study for the treatment of Duchenne muscular dystrophy.
Published:
Last Updated:
Biopharmaceutical company Rhythm Pharmaceuticals has with the SEC regarding its initial public offering.
Published:
Last Updated:
BioCryst Pharmaceuticals saw its shares make a handy gain on early Tuesday after it released the final results from its mid-stage clinical trial in hereditary angioedema.
Published:
Last Updated:
Taking more than a prescribed amount of medication leads to nearly 1.5 million calls annually to U.S. poison control centers.
Published:
Last Updated:
ImmunoGen announced this week that it has decided to partner with Jazz Pharmaceuticals, and investors have pushed Immunogen shares to a new 52-week high.
Published:
Last Updated:
ImmunoGen has decided to partner with Jazz Pharmaceuticals for the development and commercialization of two early-stage, hematology-related antibody-drug conjugate programs.
Published:
Last Updated:
Gilead Sciences shares have been in a holding pattern for a while. Analysts have said that the firm needs to make a move to shake this situation, otherwise this could turn into something worse.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks dropped.
Published:
Last Updated:
Ultragenyx Pharmaceutical shares took a turn for the worse on Wednesday after a report that results from its late-stage trial did not live up to expectations.
Published:
Last Updated:
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) shares remained relatively muted on Monday after the firm announced a key U.S. Food and Drug Administration (FDA) approval for its gout treatment...
Published:
Last Updated:
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) saw its shares make a handy gain early on Monday after the firm announced a critical update that it received from the U.S. Food and Drug Administration....
Published:
Last Updated:
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) saw its shares make a handy gain on Thursday after the company provided an update from the U.S. Food and Drug Administration (FDA)....
Published:
Last Updated: